Gastric acid and particulate aspiration injury inhibits pulmonary bacterial clearance

Critical Care Medicine

Volumn 32, Issue 3, 2004, Pages 747-754

  Rotta, Alexandre T ^a,e   Shiley, Kevin T ^b   Davidson, Bruce A ^b   Helinski, Jadwiga D ^b   Russo, Thomas A ^b,c,d   Knight, Paul R ^b,c,d  

^a UNIVERSITY AT BUFFALO   (United States)

^b Department of Anesthesiology ^*  (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d Vet Admin W New York Hlthcare S   (United States)

^e CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Acute respiratory distress syndrome; Cytokines; Escherichia coli; Gastric aspiration pneumonia

Indexed keywords

ALBUMIN; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; INTERLEUKIN 10; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION; BACTERIAL COUNT; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; CATHETER; CELL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; IN VIVO STUDY; INOCULATION; LUNG HOMOGENATE; LUNG INJURY; LUNG LAVAGE; MALE; MEASUREMENT; NECK DISSECTION; NONHUMAN; OXYGENATION; PH; PRIORITY JOURNAL; RAT; RAT STRAIN; STOMACH ACID; STOMACH SUCTION; TRACHEA;

ANIMALS; CYTOKINES; ESCHERICHIA COLI; MALE; PNEUMONIA, ASPIRATION; RATS; RATS, LONG-EVANS; REGRESSION ANALYSIS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 1542614332     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000114577.10352.46     Document Type: Article

References (48)

1. Marik PE: Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344:665-671
2. Roy TM, Ossorio MA, Cipolla LM, et al: Pulmonary complications after tricyclic antidepressant overdose. Chest 1989; 96:852-856
3. Daniels SK, Brailey K, Priestly DH, et al: Aspiration in patients with acute stroke. Arch Phys Med Rehabil 1998; 79:14-19
4. Aldrich T, Morrison J, Cesario T: Aspiration after overdosage of sedative or hypnotic drugs. South Med J 1980; 73:456-458
5. Warner MA, Warner ME, Weber JG: Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology 1993; 78:56-62
6. Olsson GL, Hallen B, Hambraeus-Jonzon K: Aspiration during anaesthesia: A computer-aided study of 185, 358 anaesthetics. Acta Anaesthesiol Scand 1986; 30:84-92
7. Marx GF, Mateo CV, Orkin LR: Computer analysis of postanesthetic deaths. Anesthesiology 1973; 39:54-58
8. Bodlander FM: Deaths associated with anaesthesia. Br J Anaesth 1975; 47:36-40
9. Milberg JA, Davis DR, Steinberg KP, et al: Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273:306-309
10. Zilberberg MD, Epstein SK: Acute lung injury in the medical ICU: Comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 1998; 157:1159-1164
11. Doyle RL, Szaflarski N, Modin GW, et al: Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152:1818-1824
12. Kennedy TP, Johnson KJ, Kunkel RG, et al: Acute acid aspiration lung injury in the rat: Biphasic pathogenesis. Anesth Analg 1989; 69:87-92
13. Knight PR, Rutter T, Tait AR, et al: Pathogenesis of gastric particulate lung injury: A comparison and interaction with acidic pneumonitis. Anesth Analg 1993; 77:754-760
14. Heyland DK, Cook DJ, Schoenfeld PS, et al: The effect of acidified enteral feeds on gastric colonization in critically ill patients: Results of a multicenter randomized trial. Canadian Critical Care Trials Group. Crit Care Med 1999; 27:2399-2406
15. Bartlett JG, Gorbach SL, Finegold SM: The bacteriology of aspiration pneumonia. Am J Med 1974; 56:202-207
16. Davidson BA, Knight PR, Helinski JD, et al: The role of tumor necrosis factor-alpha in the pathogenesis of aspiration pneumonitis in rats. Anesthesiology 1999; 91:486-499
17. Russo T, Johnson J: A proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 2000; 181:1753-1754
18. Russo T, Moffitt M, Hammer C, et al: TnphoA mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity. Infect Immun 1993; 61:3578-3582
19. Russo T, Liang Y, Cross A: The presence of K54 capsular polysaccharide increases the pathogenicity of Escherichia coli in vivo. J Infect Dis 1994; 169:112-118
20. Russo T, Sharma G, Brown C, et al: The loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect Immun 1995; 63:1263-1269
21. Russo TA, Bartholomew LA, Davidson BA, et al: Total extracellular surfactant is increased but abnormal in a rat model of Gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol 2002; 283:L655-L663
22. Russo T, Davidson B, Priore R, et al: Capsular polysaccharide and O-specific antigen divergently modulate pulmonary neutrophil influx in a rat Escherichia coli model of Gram-negative pneumonitis. Infect Immun 2000; 68:2854-2862
23. Carson RT, Vignali DA: Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999; 227:41-52
24. Croghan JE, Burke EM, Caplan S, et al: Pilot study of 12-month outcomes of nursing home patients with aspiration on videofluoroscopy. Dysphagia 1994; 9:141-146
25. Terpenning M, Bretz W, Lopatin D, et al: Bacterial colonization of saliva and plaque in the elderly. Clin Infect Dis 1993; 16(Suppl 4):S314-S316
26. Yoneyama T, Yoshida M, Matsui T, et al: Oral care and pneumonia. Oral Care Working Group. Lancet 1999; 354:515
27. Shanley TP, Davidson BA, Nader ND, et al: Role of macrophage inflammatory protein-2 in aspiration-induced lung injury. Crit Care Med 2000; 28:2437-2444
28. Laichalk LL, Kunkel SL, Strieter RM, et al: Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun 1996; 64: 5211-5218
29. Gosselin D, DeSanctis J, Boule M, et al: Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun 1995; 63:3272-3278
30. Wang CM, Tang RB, Chung RL, et al: Tumor necrosis factor-alpha and interleukin-6 profiles in children with pneumonia. J Microbiol Immunol Infect 1999; 32:233-238
31. Buck C, Gallati H, Pohlandt F, et al: Increased levels of tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) in tracheal aspirates of newborns with pneumonia. Infection 1994; 22:238-241
32. Moussa K, Michie HJ, Cree IA, et al: Phagocyte function and cytokine production in community acquired pneumonia. Thorax 1994; 49:107-111
33. Waage A, Shalaby R, Espevik T: Tumor necrosis factor, interleukin-1, interleukin-6, interleukin-8 and interferon-g in septic shock. In: Cytokines in Health and Disease. Kunkel S, Remik D (Eds). New York, Marcel Dekker, 1992, pp 151-164
34. Standiford TJ: Cytokines and pulmonary host defenses. Curr Opin Pulm Med 1997; 3:81-88
35. Voll RE, Herrmann M, Roth EA, et al: Immunosuppressive effects of apoptotic cells. Nature 1997; 390:350-351
36. Howard M, O'Garra A, Ishida H, et al: Biological properties of interleukin 10. J Clin Immunol 1992; 12:239-247
37. Cassatella MA, Meda L, Bonora S, et al: Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 78:2207-2211
38. Kasama T, Strieter RM, Lukacs NW, et al: Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994; 152:3559-3569
39. Ralph P, Nakoinz I, Sampson-Johannes A, et al: IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992; 148:808-814
40. Howard M, Muchamuel T, Andrade S, et al: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177:1205-1208
41. Greenberger MJ, Strieter RM, Kunkel SL, et al: Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 1995; 155:722-729
42. Leonard EJ, Yoshimura T: Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990; 11:97-101
43. Bossink AW, Paemen L, Jansen PM, et al: Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 1995; 86:3841-3847
44. Chensue SW, Warmington KS, Ruth JH, et al: Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: Relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 1996; 157:4602-4603
45. Sylvester I, Suffredini AF, Boujoukos AJ, et al: Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J Immunol 1993; 151:3292-3298
46. Zisman DA, Kunkel SL, Strieter RM, et al: MCP-1 protects mice in lethal endotoxemia. J Clin Invest 1997; 99:2832-2836
47. Rutledge BJ, Rayburn H, Rosenberg R, et al: High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 1995; 155:4838-4843
48. Nakano Y, Kasahara T, Mukaida N, et al: Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect Immun 1994; 62:377-383